Alvotech Ordinary Shares
ALVOStock
$3.37−62.92%52W
Market Cap$1.14B
P/E40.95x
Div yield—
Beta0.20
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-36.62%
Price vs S&P 500 (4W)-21.77%
VGM Score39.56
Market Capitalization$1.14B
P/E Ratio (Annual)40.95x
Earnings Surprise History
Q1 26-0.09est. 0.02
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.92
3.92
3.92
3.92
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ALVOAlvotech Ordinary Shares | C | D | D | $3.37 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
Alvotech is an integrated biopharmaceutical company that develops and manufactures biosimilar medicines. The company creates affordable alternatives to existing biologic therapies, expanding patient access to treatments while leveraging its integrated research, development, and manufacturing capabilities.